HUNTINGTON NATIONAL BANK - GW PHARMACEUTICALS PLC ownership

GW PHARMACEUTICALS PLC's ticker is GWPH and the CUSIP is 36197T103. A total of 256 filers reported holding GW PHARMACEUTICALS PLC in Q2 2018. The put-call ratio across all filers is 2.00 and the average weighting 0.1%.

Quarter-by-quarter ownership
HUNTINGTON NATIONAL BANK ownership history of GW PHARMACEUTICALS PLC
ValueSharesWeighting
Q1 2021$67,000
+86.1%
3100.0%0.00%
Q4 2020$36,000
+20.0%
3100.0%0.00%
Q3 2020$30,000
-21.1%
3100.0%0.00%
-100.0%
Q2 2020$38,000
+40.7%
3100.0%0.00%0.0%
Q1 2020$27,000
-15.6%
3100.0%0.00%
Q4 2019$32,000
-11.1%
3100.0%0.00%
-100.0%
Q3 2019$36,000
-32.1%
3100.0%0.00%0.0%
Q2 2019$53,000
+1.9%
3100.0%0.00%0.0%
Q1 2019$52,000
+73.3%
3100.0%0.00%0.0%
Q4 2018$30,000
-48.3%
310
-7.2%
0.00%0.0%
Q3 2018$58,000
+16.0%
334
-7.2%
0.00%0.0%
Q2 2018$50,000
+42.9%
360
+16.1%
0.00%0.0%
Q1 2018$35,000
-18.6%
310
-4.6%
0.00%0.0%
Q4 2017$43,000
+30.3%
3250.0%0.00%0.0%
Q3 2017$33,0000.0%3250.0%0.00%0.0%
Q2 2017$33,000
-17.5%
325
-3.0%
0.00%0.0%
Q1 2017$40,000
+14.3%
335
+8.1%
0.00%0.0%
Q4 2016$35,000
+25.0%
310
+47.6%
0.00%0.0%
Q3 2016$28,000
+47.4%
2100.0%0.00%
Q2 2016$19,0000.0%2100.0%0.00%
Q1 2016$19,000
+26.7%
2100.0%0.00%
Q4 2015$15,000
-21.1%
2100.0%0.00%
Q3 2015$19,000
-26.9%
2100.0%0.00%
-100.0%
Q2 2015$26,000
+36.8%
2100.0%0.00%
Q1 2015$19,000
+35.7%
2100.0%0.00%
Q4 2014$14,0002100.00%
Other shareholders
GW PHARMACEUTICALS PLC shareholders Q2 2018
NameSharesValueWeighting ↓
GREAT POINT PARTNERS LLC 390,000$45,010,0007.31%
Copernicus Capital Management, LLC 2,788$322,0005.02%
Integral Health Asset Management, LLC 72,500$8,367,0002.49%
Parkman Healthcare Partners LLC 81,573$9,414,0002.41%
AdvisorShares Investments LLC 66,317$7,654,0001.78%
Tri Locum Partners LP 40,159$4,635,0001.68%
ETF MANAGERS GROUP, LLC 621,361$71,711,0001.57%
Redmile Group, LLC 815,681$94,138,0001.14%
Redwood Investments, LLC 108,999$12,580,0001.07%
ROOSEVELT INVESTMENT GROUP LLC 127,885$14,759,0001.05%
View complete list of GW PHARMACEUTICALS PLC shareholders